Online Trial Tracker - Larvol Sigma

ganitumab (AMG 479) / Takeda, ImmunityBio

Welcome, Profile Billing Logout

1 Trials

Active Trials Industry lead sponsorIndustry collaborator

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

ganitumab (AMG 479) / Takeda, ImmunityBio

NCT03029481: Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma

No Longer Available

N/A

Ganitumab, AMG 479

Jonsson Comprehensive Cancer Center, NantCell, Inc.

Ewing Sarcoma

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites